KYTX
Kyverna Therapeutics Inc.
Company Overview
| Mkt Cap | $250.82M | Price | $6.97 |
| Volume | 368.43K | Change | +3.26% |
| P/E Ratio | -2.0 | Open | $6.75 |
| Revenue | -- | Prev Close | $6.75 |
| Net Income | $-127.5M | 52W Range | $1.78 - $8.45 |
| Div Yield | N/A | Target | $20.50 |
| Overall | 54 | Value | 60 |
| Quality | 36 | Technical | 66 |
No chart data available
Stock Overview
Updated DailyKyverna Therapeutics Inc. (KYTX) is a leading diversified company in the business industry, currently trading at $6.97 with a market capitalization of $250.82 million. The stock is positioned in the upper portion of its trading range, demonstrating concerning quality fundamentals with a MarketXLS quality score of 36.
Today's trading session shows KYTX with a volume of 368K shares. The stock opened down 0.00% from yesterday's close of $6.75. Current analyst estimates project earnings of $-3.86 per share for this year, with next year targeting $-3.67.
KYTX demonstrates positive technical signals based on technical analysis. The company trades on the NGS exchange.
Key investment considerations for KYTX include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 194.1%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 08:11 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KYTX | $6.97 | +3.3% | 368.43K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Kyverna Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW